MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Pathological neuronal Oscillations in an animal model of Rapid-Onset Dystonia-Parkinsonism

M. Möller, J. Nieweler, M. Bähr, C. Van-Riesen (Göttingen, Germany)

Meeting: 2023 International Congress

Abstract Number: 1246

Keywords: Rapid-onset dystonia-parkinsonism(RDP)

Category: Pathophysiology (Other Movement Disorders)

Objective: The aim of our study was to investigate neuronal network activity in the basal ganglia (BG) and cerebellum (CB) in Rapid-Onset Dystonia-Parkinsonism (RDP).

Background: RDP is a rare neurological disease caused by ATP1A3 mutation. Symptoms are characterized by the sudden onset of both dystonia and parkinsonism, which manifest after stressful events and remain stable. Currently, there are no treatment options. Ouabain is a highly selective toxin, blocking the a3-subunit activity of a Na+-/K+-ATPase that can be used to model RDP in rodents. Recent studies showed that an Ouabain infusion into BG induces parkinsonism, whereas dystonia can be generated by an infusion into CB. A combined infusion at both sites induces dystonia-parkinsonism similar to the human disease. Prior publications support that disease symptoms in RDP are mediated by a combined dysfunction of BG and CB. However, the underlying network disorder has not been sufficiently explored so far.

Method: We infused Ouabain in rats by osmotic pumps either in the CB, striatum (STR) or at both places simultaneously. Motor behavior was scored using published rating systems. After the onset of symptoms, we performed parallel in vivo recordings of local field potentials (LFP) under urethane anesthesia from the primary cortex (M1), deep cerebellar nuclei (DCN) and substantia nigra reticulata (SNr). Data was compared with untreated controls.

Results: Rats with Ouabain infusion into CB developed severe dystonia. Peak frequency power and coherence showed a highly significant increase in gamma activity (55-80 Hz) in all recorded network nuclei compared to the controls (Average peaks [Hz] M1: 65, SNr: 66, DCN: 65). In contrast striatal Ouabain infusion resulted in akinetic animals. Analysis of the LFPs revealed a significant increase in beta oscillations (13-30 Hz, peak frequencies [Hz] DCN: 19, SNr: 20, M1: 22). In addition, we observed a significant decrease in the gamma power. Rats with a combined infusion into STR/CB developed dystonia-parkinsonism. Beta power was increased in the DCN, whereas gamma activity decreased in M1, SNr and DCN. Coherence analysis demonstrated a significant elevation of beta activity between CB and BG. However, gamma coherence was significantly reduced.

Conclusion: In our animal model of RDP gamma oscillations were related to dystonic symptoms, whereas beta oscillations were related to parkinsonism and dystonia-parkinsonism.

To cite this abstract in AMA style:

M. Möller, J. Nieweler, M. Bähr, C. Van-Riesen. Pathological neuronal Oscillations in an animal model of Rapid-Onset Dystonia-Parkinsonism [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/pathological-neuronal-oscillations-in-an-animal-model-of-rapid-onset-dystonia-parkinsonism/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/pathological-neuronal-oscillations-in-an-animal-model-of-rapid-onset-dystonia-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley